Chris is a Senior Research Development Manager at the MBHI with over 14 years of experience in grant administration, interdisciplinary collaboration, and proposal development. A 2024 ASGII “Rising Star” Award recipient, he has secured multi-million-dollar funding and is recognized for his leadership, mentorship, and team training.
Have a Brain Health Project in Mind?
Whether you’re looking to explore an idea, discuss possibilities, or get guidance on developing your project, we’re here to help.
Spotlight Funding Opportunity
BrightFocus Foundation Alzheimer's Disease Research (ADR) Program
The BrightFocus Foundation is seeking innovative research proposals that advance the understanding, prevention, treatment, and cure of Alzheimer's disease and related dementias. The program supports highly innovative projects that may be difficult to fund through traditional mechanisms.
Funding is intended to accelerate breakthrough discoveries by supporting early-stage, high-risk/high-reward research from investigators exploring novel approaches to Alzheimer's disease and brain health.
Research Areas of Interest
- Mechanisms underlying Alzheimer's disease and related dementias
- Early detection and diagnostic approaches
- Novel therapeutic targets and interventions
- Neuroinflammation, resilience, and disease progression
- Innovative technologies and translational research strategies
Funding Highlights
- Supports early-career and established investigators
- Encourages innovative, high-impact ideas
- Focus on projects with strong potential to advance the field
Investigators interested in Alzheimer's disease and dementia research are encouraged to review the current Request for Proposals and application requirements.
Learn More
Past Human Brain Talk
Ara is a Senior Research Development Manager at the MBHI, specializing in grant writing, publications, and program management. With a background in neuroscience, microbiology, and military journalism, he has co-authored numerous scientific papers, secured multi-million-dollar grants, and previously supported infectious disease research at the GNL.
